Literature DB >> 15647960

Do subjective symptoms of obstructive voiding correlate with post-void residual urine volume in women?

Mesfer Al-Shahrani1, Danny Lovatsis.   

Abstract

The objective was to determine if symptoms of obstructive voiding correlate with post-void residual urine volume measured by catheterization. A cross-sectional study of 134 consecutive women referred to a tertiary urogynecology clinic was performed. Subjects were interviewed regarding three types of obstructive voiding symptoms: a sensation of incomplete emptying, straining to void, and slow urine stream. Post-void residual urine volume was measured by catheterization as the gold standard. Data for each symptom were analyzed using Cohen's kappa test, sensitivity, specificity, likelihood ratios for a positive of negative test, and positive and negative predictive values. A total of 11 out of 134 patients (8%) had a post-void residual volume greater than 100 ml. Of these 11, 1 had symptoms of incomplete emptying (9%), 1 had symptoms of straining to void (9%), and 2 had symptoms of slow urine stream (18%). Sensitivity, specificity, likelihood ratio for a positive symptom, likelihood ratio for a negative symptom, positive predictive value, negative predictive value, and Cohen's kappa, respectively, were 9%, 80%, 0.47, 1.13, 4%, 91%, and 0.05 for the symptom of incomplete emptying, 9%, 91%, 1.12, 1.0, 8%, 92%, and 0.01 for straining to void, and 18%, 89%, 1.6, 0.92, 13%, 92%, and 0.07 for the symptom of slow urine stream. It was concluded that symptoms of obstructive voiding do not correlate with measured post-void urine volume. In clinically important situations, these symptoms cannot substitute for measurement of post-void residual urine volume.

Entities:  

Mesh:

Year:  2004        PMID: 15647960     DOI: 10.1007/s00192-004-1202-4

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  13 in total

1.  Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

Authors:  R A Appell; P Sand; R Dmochowski; R Anderson; N Zinner; D Lama; M Roach; J Miklos; D Saltzstein; T Boone; D R Staskin; D Albrecht
Journal:  Mayo Clin Proc       Date:  2001-04       Impact factor: 7.616

2.  Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

Authors:  P Van Kerrebroeck; K Kreder; U Jonas; N Zinner; A Wein
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

3.  Clinical predictors of urinary incontinence in women.

Authors:  G W Cundiff; R L Harris; K W Coates; R C Bump
Journal:  Am J Obstet Gynecol       Date:  1997-08       Impact factor: 8.661

4.  Prevalence and characteristics of voiding difficulties in women: are subjective symptoms substantiated by objective urodynamic data?

Authors:  A Groutz; D Gordon; J B Lessing; I Wolman; A Jaffa; M P David
Journal:  Urology       Date:  1999-08       Impact factor: 2.649

5.  Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group.

Authors:  R U Anderson; D Mobley; B Blank; D Saltzstein; J Susset; J S Brown
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

6.  Do urinary symptoms correlate with urodynamic findings?

Authors:  C Amundsen; M Lau; S F English; E J McGuire
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

7.  Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group.

Authors:  D M Gleason; J Susset; C White; D R Munoz; P K Sand
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

8.  Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire.

Authors:  G E Lemack; P E Zimmern
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

9.  Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology.

Authors:  J G Blaivas; A Groutz
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

10.  The significance of the American Urological Association symptom index score in the evaluation of women with bladder outlet obstruction.

Authors:  A Groutz; J G Blaivas; G Fait; A M Sassone; D C Chaikin; D Gordon
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

View more
  9 in total

1.  Elevated postvoid residual in women with pelvic floor disorders: prevalence and associated risk factors.

Authors:  Emily S Lukacz; Einat DuHamel; Shawn A Menefee; Karl M Luber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-06-28

Review 2.  Evaluation and management of urinary retention after a suburethral sling procedure in women.

Authors:  Lysanne Campeau; Tala Al-Afraa; Jacques Corcos
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

Review 3.  Addressing the need for a simpler algorithm for the management of women with urinary incontinence.

Authors:  Lars Viktrup
Journal:  MedGenMed       Date:  2005-08-01

4.  The evolution of surgical treatment for female stress urinary incontinence: era of mid-urethral slings.

Authors:  Young-Suk Lee; Ha Na Lee; Kyu-Sung Lee
Journal:  Korean J Urol       Date:  2010-04-20

5.  Do symptoms of voiding dysfunction predict urinary retention?

Authors:  Amos O Adelowo; Michele R Hacker; Anna Merport Modest; Eman A Elkadry
Journal:  Female Pelvic Med Reconstr Surg       Date:  2012 Nov-Dec       Impact factor: 2.091

6.  Obstructive voiding symptoms are not predictive of elevated postvoid residual urine volumes.

Authors:  Lior Lowenstein; Charles Anderson; Kimberly Kenton; Yashika Dooley; Linda Brubaker
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

7.  A Survey on Voiding Complaints in Women Presenting at a Pelvic Care Center.

Authors:  Heidi Moossdorff-Steinhauser; Kevin L J Rademakers; Fred Nieman; Gommert A van Koeveringe; Bary Berghmans
Journal:  Curr Urol       Date:  2019-09-10

8.  Voiding symptoms obtained by open versus directed anamnesis as predictors of voiding dysfunction in women.

Authors:  Juan Pablo Valdevenito; José Flores; Rodrigo Guzman Rojas; Valentin Manriquez; Leandro Arribillaga; Juan de Benito
Journal:  Int Braz J Urol       Date:  2019 Jul-Aug       Impact factor: 1.541

Review 9.  Voiding dysfunction in women: How to manage it correctly.

Authors:  A Abdel Raheem; Helmut Madersbacher
Journal:  Arab J Urol       Date:  2013-08-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.